1 – 20 of 23
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
(
- Contribution to journal › Article
-
Mark
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
(
- Contribution to journal › Article
-
Mark
Mitochondrial heteroplasmic shifts reveal a positive selection of breast cancer
(
- Contribution to journal › Article
- 2021
-
Mark
A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients
(
- Contribution to journal › Article
-
Mark
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): : initial results from an international prospective study
(
- Contribution to journal › Article
- 2015
-
Mark
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers
(
- Contribution to journal › Article
- 2011
-
Mark
Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers
(
- Contribution to journal › Article
- 2006
-
Mark
CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden
(
- Contribution to journal › Article
- 2003
-
Mark
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier
(
- Contribution to journal › Article
- 2001
-
Mark
Gene-expression profiles in hereditary breast cancer
(
- Contribution to journal › Article
-
Mark
Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer
(
- Contribution to journal › Article
-
Mark
Predictive genetic screening and clinical findings in multiple endocrine neoplasia type I families
(
- Contribution to journal › Article
- 2000
-
Mark
Cytogenetic heterogeneity and clonal evolution in synchronous bilateral breast carcinomas and their lymph node metastases from a male patient without any detectable BRCA2 germline mutation
(
- Contribution to journal › Article
-
Mark
Somatic frameshift alterations in mononucleotide repeat-containing genes in different tumor types from an HNPCC family with germline MSH2 mutation
(
- Contribution to journal › Article
- 1999
-
Mark
hMLH1, hMSH2 and hMSH6 mutations in hereditary non-polyposis colorectal cancer families from southern Sweden
(
- Contribution to journal › Article
- 1998
-
Mark
BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease
(
- Contribution to journal › Article
-
Mark
Survival of BRCA1 breast and ovarian cancer patients : a population-based study from southern Sweden
(
- Contribution to journal › Article
-
Mark
Keimbahnmutationen im MEN1-Gen : Basis für prädiktives genetisches Screening und klinisches Management von MEN1-Familien
(
- Contribution to journal › Article
-
Mark
MEN1 gene mutations in 12 MEN1 families and their associated tumors
(
- Contribution to journal › Article